Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AQXP

Aquinox

$10.57

-0.03 (-0.28%)

09:05
12/11/17
12/11
09:05
12/11/17
09:05
Recommendations
Aquinox analyst commentary at Canaccord »

FDA panel vote mitigates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
AQXP

Aquinox

$10.91

-0.49 (-4.30%)

09:41
11/08/17
11/08
09:41
11/08/17
09:41
Earnings
Breaking Earnings news story on Aquinox »

Aquinox reports Q3 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 07

    Dec

AQXP

Aquinox

$12.06

-0.41 (-3.29%)

04:55
10/25/17
10/25
04:55
10/25/17
04:55
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 07

    Dec

AQXP

Aquinox

$12.47

-0.27 (-2.12%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 07

    Dec

AQXP

Aquinox

$12.74

-0.2 (-1.55%)

06:03
10/23/17
10/23
06:03
10/23/17
06:03
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 07

    Dec

Over a quarter ago
AQXP

Aquinox

$14.62

-0.13 (-0.88%)

09:38
08/28/17
08/28
09:38
08/28/17
09:38
Hot Stocks
Aquinox issues statement on FDA committee meeting »

Aquinox Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

AQXP

Aquinox

$14.21

0.19 (1.36%)

08:07
08/17/17
08/17
08:07
08/17/17
08:07
Recommendations
Aquinox analyst commentary at Leerink »

Leerink remains positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQXP

Aquinox

$14.87

-0.05 (-0.34%)

08:26
08/08/17
08/08
08:26
08/08/17
08:26
Earnings
Breaking Earnings news story on Aquinox »

Aquinox reports Q2 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Aug

AQXP

Aquinox

$13.74

-0.27 (-1.93%)

09:17
05/09/17
05/09
09:17
05/09/17
09:17
Earnings
Aquinox reports Q1 EPS (36c), consensus (51c) »

Cash, cash equivalents,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$9.93

-0.27 (-2.65%)

, APTO

Aptose Biosciences

$0.90

0.0302 (3.47%)

04:55
05/02/17
05/02
04:55
05/02/17
04:55
Conference/Events
Bloom, Burton & Co. hold a conference »

Healthcare Investor…

NVLN

Novelion Therapeutics

$9.93

-0.27 (-2.65%)

APTO

Aptose Biosciences

$0.90

0.0302 (3.47%)

AQXP

Aquinox

$14.75

0.07 (0.48%)

AUPH

Aurinia Pharmaceuticals

$7.38

0.37 (5.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

  • 11

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.